Urgent Call for Parliamentary Intervention to Redirect CERN Funding Towards Life-Saving Innovations
The Crosetto Foundation highlights decades of misallocated funding at CERN, advocating for the adoption of Dario Crosetto's 3D-Flow technology to save billions in taxpayer money and accelerate advancements in cancer detection and particle physics.
The Crosetto Foundation for the Reduction of Cancer Deaths has issued an urgent appeal to Members of the European Parliament to intervene in the misallocation of public funding at CERN. At the heart of the issue is Dario Crosetto's 3D-Flow technology, a breakthrough invention since 1992, which promises significant advancements in particle physics and early cancer detection through the 3D-CBS (3D-Complete Body Screening) technology.
Despite its proven superiority in flexibility, performance, and cost-effectiveness, CERN has continued to invest in Field Programmable Gate Array (FPGA)-based architectures, which have repeatedly failed to meet performance needs. This decision has not only wasted billions in taxpayer funds but also delayed the potential life-saving benefits of Crosetto's technology in medicine and defense.
The Foundation's call to action underscores the need for a public scientific comparison between CERN's current FPGA-based system and Crosetto's 3D-Flow architecture. Such a comparison could redirect funding towards more efficient and cost-effective technologies, ensuring the responsible use of taxpayer money and accelerating the adoption of innovations that could save lives and reduce healthcare costs.
This situation highlights broader issues of transparency, accountability, and the need for open scientific evaluations in taxpayer-funded research. The Crosetto Foundation's appeal to the European Parliament seeks to address these concerns, advocating for a shift in funding priorities that align with the public interest and the advancement of science.